Literature DB >> 25360843

Adrenomedullin in Vascular Endothelial Injury and Combination Therapy: Time for a New Paradigm.

Ming Yuan, Qiurong Wang, Chengxiang Li, Ling Tao, Haifeng Zhang, Haichang Wang, Yingmei Zhang, Jun Ren1.   

Abstract

Adrenomedullin is a highly conserved vasoactive peptide participating in a variety of physiological and pathophysiological processes including pregnancy, embryonic development, tumor progression and regulation of vascular tone. In particular, adrenomedullin expression is widely distributed throughout the cardiovascular system including heart, lungs, blood vessels and kidneys. The observation that adrenomedullin co-localizes with its receptors suggests that the peptide may act as an autocrine and/or paracrine factor in the regulation of cardiovascular function. In this review, we described the pathophysiological changes in plasma and local adrenomedullin associated with vascular endothelial function and the signaling mechanisms involved. Recent evidence has depicted a unique role of adrenomedullin in the regulation of vascular endothelial function in part through regulation of cAMP, cGMP and intracellular Ca(2+) mobilization. This review summarized vascular endothelial actions of adrenomedullin under both physiological and pathophysiological conditions in an effort to provide guidance for the clinical application of adrenomedullin in vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25360843     DOI: 10.2174/1570161112666141014145735

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  7 in total

1.  Adrenomedullin surges are linked to acute episodes of the systemic capillary leak syndrome (Clarkson disease).

Authors:  Zhihui Xie; Wei-Sheng Chen; Yuzhi Yin; Eunice C Chan; Kaoru Terai; Lauren M Long; Timothy G Myers; Arkadiusz Z Dudek; Kirk M Druey
Journal:  J Leukoc Biol       Date:  2018-01-23       Impact factor: 4.962

2.  Neohesperidin Protects Angiotensin II-Induced Hypertension and Vascular Remodeling.

Authors:  Jingsi Zhang; Yuanshu Hui; Fengyi Liu; Qian Yang; Yi Lu; Yeting Chang; Qinlong Liu; Yanchun Ding
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

3.  Editorial: Combination Therapy of Vascular Diseases and Fangjiomics: When West Meets East in the Era of Phenomics.

Authors:  Zhong Wang; Dayue Darrel Duan; Yong-Yan Wang
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

Review 4.  The roles of epicardial adipose tissue in heart failure.

Authors:  Ying Song; Fei Song; Chan Wu; Yi-Xiang Hong; Gang Li
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

5.  Expression of adrenomedullin in rats after spinal cord injury and intervention effect of recombinant human erythropoietin.

Authors:  Liang Zhao; Yu Jing; Lin Qu; Xiangwei Meng; Yang Cao; Huibing Tan
Journal:  Exp Ther Med       Date:  2016-10-21       Impact factor: 2.447

6.  Plasmid pLXSN-Mediated Adrenomedullin Gene Therapy for Cerebral Vasospasm Following Subarachnoid Hemorrhage in Rats.

Authors:  Xin Li; Xiaoshuang Xia; Xin Li
Journal:  Med Sci Monit       Date:  2017-07-07

Review 7.  ETV2/ER71 Transcription Factor as a Therapeutic Vehicle for Cardiovascular Disease.

Authors:  Dong Hun Lee; Tae Min Kim; Joo Kyung Kim; Changwon Park
Journal:  Theranostics       Date:  2019-08-09       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.